Goldman Sachs Group Inc Bristol Myers Squibb CO Transaction History
Goldman Sachs Group Inc
- $613 Billion
- Q4 2024
A detailed history of Goldman Sachs Group Inc transactions in Bristol Myers Squibb CO stock. As of the latest transaction made, Goldman Sachs Group Inc holds 12,303,370 shares of BMY stock, worth $734 Million. This represents 0.11% of its overall portfolio holdings.
Number of Shares
12,303,370
Previous 12,710,302
3.2%
Holding current value
$734 Million
Previous $658 Million
5.8%
% of portfolio
0.11%
Previous 0.11%
Shares
20 transactions
Others Institutions Holding BMY
# of Institutions
2,760Shares Held
1.57BCall Options Held
28MPut Options Held
28.7M-
Vanguard Group Inc Valley Forge, PA190MShares$11.3 Billion0.19% of portfolio
-
Black Rock Inc. New York, NY159MShares$9.46 Billion0.15% of portfolio
-
Jpmorgan Chase & CO New York, NY96MShares$5.72 Billion0.44% of portfolio
-
State Street Corp Boston, MA95.1MShares$5.67 Billion0.22% of portfolio
-
Charles Schwab Investment Management Inc San Francisco, CA60.3MShares$3.6 Billion0.65% of portfolio
About BRISTOL MYERS SQUIBB CO
- Ticker BMY
- Exchange NYSE
- Sector Healthcare
- Industry Drug Manufacturers—General
- Shares Outstandng 2,126,160,000
- Market Cap $127B
- Description
- Bristol-Myers Squibb Company discovers, develops, licenses, manufactures, and markets biopharmaceutical products worldwide. It offers products for hematology, oncology, cardiovascular, immunology, fibrotic, neuroscience, and covid-19 diseases. The company's products include Revlimid, an oral immunomodulatory drug for the treatment of multiple my...